Intellectus Partners’s cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock YCBD.PRA Stock Holding History

Intellectus Partners’s Portfolio YCBD.PRA Stock Details YCBD.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,000	Closed	-$73K	–	273
2021 Q4	$73K	Buy	+12,000	New	+$73.4K	0.02%	263

Other funds holding YCBD.PRA

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Camelot Portfolios Maumee, Ohio $143M AUM 14.82% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Intellectus Partners's YCBD.PRA Position: Q1 2022 in Review

Intellectus Partners sold out of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) in Q1 2022, closing a stake of 12,000 shares — an estimated $73K sold.

Intellectus Partners first reported a position in YCBD.PRA in Q4 2021 and held it in 1 quarter. The position peaked at $73K in Q4 2021. 4 funds tracked by Wall St. Rank hold YCBD.PRA as of Q1 2022.

Intellectus Partners reported no remaining cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position as of Q1 2022 after selling out during the quarter.
Intellectus Partners sold 12,000 cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock shares in Q1 2022, an estimated $73K.
Intellectus Partners first reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in Q4 2021 and held it in 1 quarter.
Intellectus Partners's cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position peaked at $73K in Q4 2021.
4 funds tracked by Wall St. Rank held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock as of Q1 2022.

Based on Intellectus Partners's 13F filing for Q1 2022, filed 16 May 2022.